Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acular LS vs. Nevanac in Post-op Inflammation
NCT00348582Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-operative inflammation and postoperative pain comparing Ketorolac Group with Nepafenac Group (2 arms). Primary endpoints: Postoperative Pain Level and Anterior Chamber Inflammation. Status: completed.
02
Drugs
ketorolacnepafenac
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT00348582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348582.